Authors
Latest:
Improving Adherence With Immunization SchedulesAs a whole, adult vaccination coverage has remained unchanged without significant improvement.
Latest:
Impact of Antidepressant Therapy on Statin Adherence and Cholesterol ControlAmong patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Christiana Care Implements Formulary Decision Process Focused on ValueThe new process takes into account the efficacy, risk, cost, and societal benefit of a given specialty drug in determining whether it should be added to the hospital's formulary.
Latest:
Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 DiabetesDiabetes is a complex disease affecting 29.1 million individuals in the United States.
Latest:
Personal Medical Liaison to Help Transition Between Hospital and HomeA new healthcare role will help bridge the gap between hospital, primary care, and home for patients.
Latest:
Low Reporting of Medicaid Diabetes Quality Measures: Room for Improvement?In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
A Collaborative Approach to Specialty Pharmacy at an Academic Medical CenterThe SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.
Latest:
Hormone Therapy Adherence and Costs in Women With Breast CancerSuboptimal adherence to hormone therapy was associated with higher medical costs, but optimal adherence was not associated with total cost savings across a 4-year period.
Latest:
Breaking Through Breakthrough Cancer PainBreakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled
Latest:
The Role of the Community Pharmacist in Managing Long-Acting Reversible ContraceptionThis Continuing Education activity is supported by an educational grant from Teva Pharmaceuticals and Merck Sharp & Dohme Corp.
Latest:
"Superbug" Exposure Reported at UCLA HospitalMore than 100 patients at a hospital in Los Angeles may have been exposed to a "superbug" that has been linked to at least 2 deaths at the facility.
Latest:
ERLEADA for Prostate CancerOn February 14, 2018, the FDA approved apalutamide (Erleada) by Janssen Biotech Inc for the treatment of nonmetastatic castration-resistant prostate cancer (NM-CRPC).
Latest:
Companies Target Personalized Medicine in Planned AcquisitionsA majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.
Latest:
Opdualag From Bristol Myers SquibbCombination therapy with both nivolumab and relatlimab leads to increased T-cell activation compared with monotherapy with either agent alone.
Latest:
LinkedIn to Pharmacy: A Student Pharmacist's GuideDeveloping industry connections is crucial for aspiring pharmacists.
Latest:
Poison Prevention Packaging Act Continues to Save Children’s LivesThe notable federal public health and pharmacy practice law celebrates its 50th anniversary in 2020.
Latest:
Web Exclusive: Pharmacist Glycemic Control Team Associated With Improved Perioperative Glycemic and Utilization OutcomesImplementation of a pharmacist-led glycemic control team was associated with improved glycemic control and utilization outcomes in a population of noncritically ill surgical patients.
Latest:
2010 Industry Advocate of the Year: Harry LattanzioHarry Lattanzio has started 3 businesses that meet the needs of the pharmacy industry-it is no wonder that he was chosen.
Latest:
Multiple Sclerosis: The Central Nervous System DestroyerThere is no cure for multiple sclerosis, but there are more than a dozen treatment options that aid in reducing the severity of the disease.
Latest:
Treatment of Diabetes and Angioedema RiskPharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Latest:
State Regulation of TelepharmacyState regulation of telepharmacy varies depending on the market-driven needs within each particular state.
